These findings demonstrated that MSC-derived exosomes transferring miR-133b into glioma cells could potentially inhibit EZH2 expression by blocking the Wnt/β-catenin signaling pathway, thereby suppressing glioma cell proliferation, migration, and invasion [103]. The gene discussed is EZH2; the disease is glioma.